Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Sleeping Bruxism Treatment Market

ID: MRFR/HC/47743-HCR
200 Pages
Vikita Thakur
March 2026

India Sleeping Bruxism Treatment Market Research Report By Type (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult) and By End User (Hospitals & Clinics, Dental Clinics) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Sleeping Bruxism Treatment Market Infographic
Purchase Options

India Sleeping Bruxism Treatment Market Summary

As per Market Research Future analysis, the India sleeping bruxism-treatment market size was estimated at 24.67 USD Million in 2024. The India sleeping bruxism-treatment market is projected to grow from 26.27 USD Million in 2025 to 49.21 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India sleeping bruxism-treatment market is experiencing notable growth driven by increasing awareness and technological advancements.

  • Rising awareness of dental health is significantly influencing consumer behavior in the India sleeping bruxism-treatment market.
  • Personalized treatment approaches are becoming more prevalent, catering to individual patient needs and preferences.
  • Integration of digital health solutions is enhancing treatment accessibility and patient engagement in the market.
  • The increasing incidence of bruxism and advancements in dental technology are key drivers of market growth.

Market Size & Forecast

2024 Market Size 24.67 (USD Million)
2035 Market Size 49.21 (USD Million)
CAGR (2025 - 2035) 6.48%

Major Players

Procter & Gamble (US), GlaxoSmithKline (GB), Johnson & Johnson (US), Colgate-Palmolive (US), Dentsply Sirona (US), 3M (US), Kavo Kerr (DE), Oral-B (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Sleeping Bruxism Treatment Market Trends

The sleeping bruxism-treatment market is currently experiencing notable growth. This growth is driven by increasing awareness of dental health and the rising prevalence of bruxism among various demographics. Factors such as stress, anxiety, and lifestyle changes contribute to the condition, prompting individuals to seek effective treatment options. The market is characterized by a diverse range of products, including mouthguards, dental splints, and therapeutic interventions. As consumers become more informed about the potential consequences of untreated bruxism, the demand for innovative solutions continues to rise. This trend is further supported by advancements in dental technology and a growing emphasis on preventive care within the healthcare system. In addition, the sleeping bruxism-treatment market is witnessing a shift towards personalized treatment plans tailored to individual needs. Healthcare professionals are increasingly focusing on comprehensive assessments to determine the most suitable interventions for patients. This approach not only enhances treatment efficacy but also fosters patient engagement and satisfaction. Moreover, the integration of digital health solutions, such as mobile applications for monitoring bruxism symptoms, is gaining traction. These developments indicate a promising future for the market, as stakeholders strive to address the complexities of bruxism and improve overall patient outcomes.

Rising Awareness of Dental Health

There is a growing recognition of the importance of dental health among the population. This trend is likely to drive demand for treatments aimed at managing bruxism, as individuals become more proactive in seeking solutions to prevent dental complications.

Personalized Treatment Approaches

Healthcare providers are increasingly adopting personalized treatment strategies for bruxism. This trend suggests a shift towards tailored interventions that consider individual patient profiles, potentially leading to improved treatment outcomes.

Integration of Digital Health Solutions

The incorporation of digital tools in managing bruxism is becoming more prevalent. Mobile applications and telehealth services may enhance patient monitoring and engagement, indicating a modern approach to treatment in the market.

India Sleeping Bruxism Treatment Market Drivers

Growing Focus on Mental Health

The rising awareness of mental health issues in India is influencing the sleeping bruxism-treatment market. Stress and anxiety are recognized as significant contributors to bruxism, prompting a greater emphasis on holistic treatment approaches. Mental health professionals are increasingly collaborating with dental practitioners to address the psychological aspects of bruxism. This integrated approach may lead to a broader range of treatment options, including counseling and stress management techniques, alongside traditional dental interventions. As mental health awareness continues to grow, the market could see a shift towards more comprehensive treatment plans, potentially increasing market demand.

Increasing Incidence of Bruxism

The prevalence of bruxism in India is rising, with studies indicating that approximately 8-10% of the population may be affected. This increase is likely attributed to various factors, including stress and anxiety prevalent in urban settings. As awareness of the condition grows, more individuals are seeking treatment options, thereby driving the sleeping bruxism-treatment market. The demand for effective solutions, such as dental guards and therapeutic interventions, is expected to surge as more people recognize the potential long-term consequences of untreated bruxism, including dental damage and jaw disorders.

Advancements in Dental Technology

Technological innovations in dentistry are significantly impacting the sleeping bruxism-treatment market. The introduction of advanced diagnostic tools, such as digital imaging and 3D printing, allows for more accurate assessments and personalized treatment plans. Moreover, the development of custom-fitted dental appliances has improved patient compliance and comfort. As dental professionals in India adopt these technologies, the effectiveness of treatments is likely to enhance, leading to increased patient satisfaction. This trend may contribute to a projected growth rate of around 5-7% in the market over the next few years, as more patients seek out these advanced solutions.

Regulatory Support for Dental Health Initiatives

Government initiatives aimed at improving dental health in India are likely to bolster the sleeping bruxism-treatment market. Regulatory bodies are increasingly promoting awareness campaigns and preventive measures to address oral health issues. This support may lead to enhanced funding for dental research and the development of new treatment modalities. As public health policies evolve, there may be a greater emphasis on early diagnosis and intervention for conditions like bruxism. Consequently, this regulatory environment could stimulate market growth, encouraging dental professionals to adopt innovative treatment strategies.

Rising Disposable Income and Healthcare Spending

The increase in disposable income among the Indian population contributes to the growth of the sleeping bruxism-treatment market. As individuals have more financial resources, they are more likely to invest in their health and well-being, including dental care. This trend is reflected in the rising expenditure on healthcare services, which has seen an annual growth rate of approximately 10-12%. With more people willing to pay for preventive and corrective dental treatments, the demand for bruxism-related solutions is expected to rise. This shift in consumer behavior may lead to a more competitive market landscape, with various treatment options becoming more accessible.

Market Segment Insights

By Type: Primary Bruxism (Largest) vs. Secondary Bruxism (Fastest-Growing)

In the India sleeping bruxism-treatment market, Primary Bruxism holds the largest share, reflecting its prevalence among individuals experiencing sleep-related grinding. This segment has established a robust market position owing to the widespread recognition of its effects on oral health, leading to increased demand for effective treatment solutions. Conversely, Secondary Bruxism is emerging as the fastest-growing segment, attributed to its association with various medical conditions and lifestyle factors, which are becoming more recognized in the population. The growth trends for these two segments indicate a dynamic shift in awareness and treatment options. Primary Bruxism continues to benefit from established treatment protocols and greater patient awareness, whereas Secondary Bruxism is being propelled by an increase in diagnosis related to stress, medications, and other underlying health issues. This trend underscores the importance of holistic approaches in managing bruxism, considering both lifestyle changes and targeted treatments.

Bruxism: Primary (Dominant) vs. Secondary (Emerging)

The Primary Bruxism segment is characterized by its dominance in the treatment market, largely due to its direct impact on sleep quality and overall oral health. This segment typically features a wide range of treatment options, including dental appliances, behavioral therapies, and pharmacological interventions. On the other hand, the Secondary Bruxism segment is gaining traction as it relates to various external factors such as stress and medication usage. This emerging segment requires innovative approaches to treatment, often focusing on addressing the underlying causes rather than just the symptoms. As awareness grows regarding the links between secondary causes and bruxism, increased demand for targeted therapies is expected, driving market evolution.

By Cause: Obstructive Sleep Apnea (Largest) vs. Malocclusion (Fastest-Growing)

In the India sleeping bruxism-treatment market, Obstructive Sleep Apnea occupies the largest share due to its high prevalence among adults. The segment values demonstrate varied impacts on sleep bruxism, with conditions like Gastroesophageal Reflux Disease contributing significantly as well. The distribution indicates that while Obstructive Sleep Apnea leads the market, conditions such as Malocclusion and Sleep Paralysis are emerging with notable presence, reflecting a diverse landscape of underlying causes. Growth trends indicate an upward trajectory primarily driven by increased awareness and diagnosis of related sleep disorders. The prevalence of lifestyle diseases and changes in dietary patterns are contributing factors, making Malocclusion an emerging segment that is gaining prominence among healthcare professionals. Furthermore, advancements in treatment options are fostering market growth, ensuring a comprehensive approach to management of bruxism-related conditions.

Obstructive Sleep Apnea (Dominant) vs. Malocclusion (Emerging)

Obstructive Sleep Apnea is recognized as the dominant cause in the India sleeping bruxism-treatment market, significantly influencing treatment strategies due to its direct correlation with sleep disruption and teeth grinding. This condition is typically characterized by repeated interruptions in breathing during sleep, leading to poor sleep quality and subsequent bruxism. On the other hand, Malocclusion, which refers to incorrect alignment of the teeth and jaws, is emerging as a significant concern with the potential to lead to increased bruxism episodes. The increasing number of orthodontic treatments and awareness surrounding proper dental alignment positions Malocclusion as a rising player in the market, leading to innovative treatment solutions addressing both dental and sleep health.

By Treatment: Mouth Guard (Largest) vs. Muscle Relaxants (Fastest-Growing)

In the India sleeping bruxism-treatment market, the distribution of market share among treatment options reveals a clear dominance of mouth guards, which are preferred by a significant portion of sufferers due to their effectiveness in preventing tooth wear. Other notable treatments include dental approaches and the NTI-TSS device, though they contribute less to overall market share. Medication and muscle relaxants, while essential, are utilized less frequently than the primary methods, highlighting a preference for non-invasive solutions. Growth trends within this segment indicate a rising acceptance of emerging treatments such as muscle relaxants and botulinum toxin type A injections. The increasing awareness of bruxism's impact on dental health is driving demand for preventive solutions, alongside a growing inclination towards innovative therapies. Changing lifestyles and an increase in stress-related bruxism cases further bolster the need for effective treatment options, suggesting a dynamic market ahead.

Mouth Guard (Dominant) vs. Muscle Relaxants (Emerging)

Mouth guards stand out as the dominant treatment in the segment, characterized by their practicality and effectiveness in safeguarding teeth from bruxism-related damage. They offer customizable options that cater to individual needs, making them a preferred choice among patients. Conversely, muscle relaxants are emerging as a significant treatment option, gaining traction due to their therapeutic benefits in alleviating muscle tension associated with bruxism. As awareness regarding the role of stress in bruxism rises, the preference for muscle relaxants is expected to grow. This reflects a shift towards a comprehensive approach to treatment, where both preventive and therapeutic strategies coexist, addressing the multifaceted nature of the condition.

By Patient Type: Adult (Largest) vs. Pediatric (Fastest-Growing)

In the India sleeping bruxism-treatment market, the patient type segment is prominently distributed between adults and pediatric patients. Adults hold the largest share, driven by higher incidences of stress-related bruxism. This segment showcases a strong preference for various treatment modalities tailored to their lifestyle and specific dental needs. The pediatric segment, while smaller, is gaining traction as awareness about sleep disorders in children rises, prompting caregivers to seek treatment solutions. The growth trends within the patient type segment indicate a significant shift towards pediatric treatments, marking it as the fastest-growing segment. Factors contributing to this trend include increased parental awareness of dental health issues, the prevalence of bruxism among children, and the introduction of child-friendly treatment options. As such, healthcare providers are more inclined to develop targeted therapies that cater specifically to this demographic, ensuring a balance between efficacy and comfort for younger patients.

Adult: Dominant vs. Pediatric: Emerging

The adult segment is characterized by a well-established market presence, with a broad array of treatments available that address the common symptoms of bruxism in this age group. This demographic often includes individuals dealing with stress, anxiety, and other lifestyle factors that exacerbate the condition. As a result, they benefit from various options such as mouthguards, stress management therapies, and pharmacological interventions. Conversely, the pediatric segment is emerging rapidly, driven by growing concerns regarding sleep disorders in children. This emerging market is focused on innovative approaches tailored to children, encompassing not only traditional dental care but also behavioral therapies. Overall, the distinction between these segments highlights the unique needs and treatment approaches required to effectively manage bruxism across different age groups.

By End User: Dental Clinics (Largest) vs. Hospitals & Clinics (Fastest-Growing)

In the India sleeping bruxism-treatment market, the Dental Clinics segment currently holds the largest market share. These clinics are well-equipped with specialized resources and trained personnel, allowing them to effectively address bruxism-related issues. The focus on personalized patient care and the prevalence of dental professionals in urban areas enhances the accessibility and popularity of dental clinics as a primary treatment option for bruxism. On the other hand, Hospitals & Clinics are emerging as the fastest-growing segment, driven by the integration of multidisciplinary approaches to treat bruxism. Factors such as increased awareness of sleep disorders, rising disposable incomes, and the growing prevalence of stress-related conditions contribute to the growth of this segment. Hospitals offer comprehensive treatment options, including medical consultations, which are crucial for patients seeking holistic care.

Dental Clinics (Dominant) vs. Hospitals & Clinics (Emerging)

Dental Clinics have established themselves as the dominant players in the India sleeping bruxism-treatment market due to their specialized focus on dental health and the treatment of bruxism. These clinics offer tailored therapies and devices to manage bruxism effectively. Their prominence is underscored by the growing number of patients seeking treatment in urbanized areas where awareness of dental health is rising. Conversely, Hospitals & Clinics represent an emerging segment that is expanding to incorporate various treatment modalities. This includes not only dental interventions but also medical evaluations and lifestyle consultations, catering to the holistic needs of patients. This integration of services positions Hospitals & Clinics as a valuable option for patients seeking comprehensive management of their bruxism.

Get more detailed insights about India Sleeping Bruxism Treatment Market

Key Players and Competitive Insights

The sleeping bruxism-treatment market in India is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on consumer health awareness. Key players such as Procter & Gamble (US), GlaxoSmithKline (GB), and Johnson & Johnson (US) are actively engaged in enhancing their product offerings and expanding their market presence. Procter & Gamble (US) has positioned itself as a leader in consumer health products, emphasizing the development of innovative oral care solutions that address bruxism. Meanwhile, GlaxoSmithKline (GB) appears to be focusing on research and development to create effective therapeutic options, while Johnson & Johnson (US) is leveraging its extensive distribution network to enhance accessibility to its bruxism-related products. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and consumer engagement are paramount.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach not only enhances responsiveness to market demands but also aligns with the growing trend of sustainability in manufacturing processes. The competitive structure of the market is moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set benchmarks for quality and innovation that smaller firms strive to meet.

In October Procter & Gamble (US) announced a partnership with a leading dental research institute to develop a new line of night guards specifically designed for bruxism sufferers. This collaboration is strategically important as it combines consumer insights with clinical expertise, potentially leading to products that are more effective and tailored to user needs. Such initiatives may enhance brand loyalty and market penetration.

In September GlaxoSmithKline (GB) launched a digital health platform aimed at educating consumers about bruxism and its treatment options. This move reflects a growing trend towards digitalization in healthcare, allowing the company to engage directly with consumers and provide valuable resources. By positioning itself as a thought leader in bruxism awareness, GlaxoSmithKline (GB) may strengthen its market position and drive product adoption.

In August Johnson & Johnson (US) expanded its product line to include a new range of herbal-based oral care products targeting bruxism. This strategic diversification not only caters to the increasing consumer preference for natural remedies but also aligns with broader health trends. By tapping into this niche market, Johnson & Johnson (US) could potentially capture a segment of health-conscious consumers seeking alternative solutions.

As of November the competitive trends in the sleeping bruxism-treatment market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming more prevalent, allowing companies to pool resources and expertise to innovate more effectively. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and reliable supply chains. This shift underscores the importance of adapting to consumer preferences and market dynamics in a rapidly changing landscape.

Key Companies in the India Sleeping Bruxism Treatment Market include

Industry Developments

The India Sleeping Bruxism Treatment Market is witnessing significant developments, particularly with companies such as Zydus Cadila, Novartis, and GlaxoSmithKline investing in innovative treatment solutions. The rise in awareness regarding sleep disorders has led to increased demand for effective therapies.

In July 2023, Sun Pharmaceutical Industries launched a new product aimed at treating bruxism, reflecting the company's commitment to expanding its portfolio. The overall market valuation has been positively impacted as Abbott Laboratories and Dr. Reddy's Laboratories enhance their presence through collaborations and product developments.

Notably, Hindustan Unilever is exploring natural remedies, aligning with the growing trend towards holistic health approaches. Additionally, in May 2022, Pfizer acquired smaller biotech firms specializing in sleep disorders, which could lead to advancements in bruxism treatment options.

The integration of technology in treatments, coupled with heightened focus from multinational companies like Johnson and Johnson and Bayer, marks a dynamic shift in this sector. Over the past few years, investments in Research and Development have surged, significantly altering the competitive landscape and helping to address the unmet needs within the Indian population suffering from sleep bruxism.

Future Outlook

India Sleeping Bruxism Treatment Market Future Outlook

The Sleeping Bruxism Treatment Market is projected to grow at a 6.48% CAGR from 2025 to 2035, driven by increasing awareness and innovative treatment options.

New opportunities lie in:

  • Development of customized oral appliances for enhanced comfort and effectiveness.
  • Integration of telehealth services for remote consultations and follow-ups.
  • Expansion of educational programs targeting dental professionals and patients.

By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and treatment advancements.

Market Segmentation

India Sleeping Bruxism Treatment Market Type Outlook

  • Primary Bruxism
  • Secondary Bruxism

India Sleeping Bruxism Treatment Market Cause Outlook

  • Obstructive Sleep Apnea
  • Gastroesophageal Reflux Disease (GERD)
  • Malocclusion
  • Sleep Paralysis

India Sleeping Bruxism Treatment Market End User Outlook

  • Hospitals & Clinics
  • Dental Clinics

India Sleeping Bruxism Treatment Market Treatment Outlook

  • Dental Approaches
  • Mouth Guard
  • NTI-TSS Device
  • Medication
  • Muscle Relaxants
  • Botulinum toxin type A Injections
  • Anti-anxiety Drugs

India Sleeping Bruxism Treatment Market Patient Type Outlook

  • Pediatric
  • Adult
  • Male
  • Female

Report Scope

MARKET SIZE 2024 24.67(USD Million)
MARKET SIZE 2025 26.27(USD Million)
MARKET SIZE 2035 49.21(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.48% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Procter & Gamble (US), GlaxoSmithKline (GB), Johnson & Johnson (US), Colgate-Palmolive (US), Dentsply Sirona (US), 3M (US), Kavo Kerr (DE), Oral-B (US)
Segments Covered Type, Cause, Treatment, Patient Type, End User
Key Market Opportunities Emerging technologies in oral appliances enhance effectiveness in the sleeping bruxism-treatment market.
Key Market Dynamics Rising consumer awareness drives demand for innovative sleeping bruxism treatments amid evolving regulatory frameworks.
Countries Covered India
Author
Author
Author Profile
Vikita Thakur LinkedIn
Senior Research Analyst
She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Leave a Comment

FAQs

What is the current valuation of the India sleeping bruxism-treatment market?

<p>The market valuation was $24.67 Million in 2024.</p>

What is the projected market size for the India sleeping bruxism-treatment market by 2035?

<p>The market is projected to reach $49.21 Million by 2035.</p>

What is the expected CAGR for the India sleeping bruxism-treatment market during the forecast period 2025 - 2035?

<p>The expected CAGR is 6.48% during the forecast period.</p>

Which companies are the key players in the India sleeping bruxism-treatment market?

<p>Key players include Procter & Gamble, GlaxoSmithKline, Johnson & Johnson, and Colgate-Palmolive.</p>

What are the primary and secondary bruxism market segments valued at?

<p>Primary bruxism is valued between $10.0 Million and $20.0 Million, while secondary bruxism ranges from $14.67 Million to $29.21 Million.</p>

What causes are associated with the India sleeping bruxism-treatment market?

<p>Causes include obstructive sleep apnea, gastroesophageal reflux disease (GERD), malocclusion, and sleep paralysis.</p>

What treatment options are available in the India sleeping bruxism-treatment market?

<p>Treatment options include dental approaches, mouth guards, NTI-TSS devices, medication, muscle relaxants, botulinum toxin type A injections, and anti-anxiety drugs.</p>

How is the patient demographic segmented in the India sleeping bruxism-treatment market?

<p>The patient demographic is segmented into pediatric, adult, male, and female categories.</p>

What are the end-user segments in the India sleeping bruxism-treatment market?

<p>End-user segments include hospitals & clinics and dental clinics.</p>

What is the significance of the dental clinics segment in the market?

<p>The dental clinics segment is valued between $14.67 Million and $29.21 Million, indicating its substantial role in the market.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions